| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Enliven Therapeutics, Inc. (ELVN) has 10 insiders with recent SEC Form 4 filings, including 4 buys and 20 sells. ELVN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 890.4K | $40.92M | - | |
| CEO | 875.0K | $40.22M | - | |
| Other | 740.2K | $34.02M | - | |
| 10% | 245.7K | $11.29M | -281,408 | |
| COO | 215.0K | $9.88M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 3, 2022 | New Enterprise Associates 14, L.P. | 10% Owner | Sell | 116,476 | $2.29 | $266,870.49 | -1.1% | -32.4% | +63.5% | |
| Dec 29, 2021 | New Enterprise Associates 14, L.P. | 10% Owner | Sell | 67,427 | $2.37 | $159,499.83 | -0.6% | -14.4% | +75.5% | |
| Dec 23, 2021 | New Enterprise Associates 14, L.P. | 10% Owner | Sell | 291,152 | $2.36 | $688,499.19 | -0.7% | -19.7% | +69.9% | |
| Jul 16, 2021 | Chin Mark | Director | Buy | 1,333,333 | $6.00 | $7,999,998.00 | +131.9% | -31.7% | -79.3% | |
| Jul 16, 2021 | Bonita David P66 | Director, 10% Owner | Buy | 1,666,666 | $6.00 | $9,999,996.00 | New | -31.7% | -79.3% | |
| Jul 16, 2021 | Orbimed Advisors LLC67 | Director, 10% Owner | Buy | 1,666,666 | $6.00 | $9,999,996.00 | New | -31.7% | -79.3% | |
| Dec 17, 2020 | Ballal Rahul D.70 | Chief Executive Officer | Sale+OE | 4,999 | $25.00 | $124,975.00 | -100% | - | - | |
| Dec 14, 2020 | Ballal Rahul D.70 | Chief Executive Officer | Sale+OE | 1 | $25.00 | $25.00 | -100% | - | - | |
| Dec 11, 2020 | Gray Michael | CFO &COO | Sale+OE | 1,250 | $25.00 | $31,250.00 | -100% | - | - | |
| Mar 16, 2020 | Agger Mette Kirstine | Director, 10% Owner | Buy | 187,500 | $16.00 | $3,000,000.00 | +15.1% | - | - |